NDAORALCAPSULE, EXTENDED RELEASE
Approved
Jul 2013
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of reuptake at serotonin and norepinephrine transporters. Non-clinical studies have shown that levomilnacipran is a potent and selective serotonin and…
Indications (1)
Loss of Exclusivity
LOE Date
May 23, 2032
75 months away
Patent Expiry
May 23, 2032
Exclusivity Expiry
Mar 24, 2026